Consistent with this, Lacoste et al. demonstrated that bombesin, a substrate of NEP, induces motility of PC-3 prostate cancer cells via activation (tyrosine phosphorylation) of FAK [155]. The gene discussed is MME; the disease is prostate carcinoma.